Gracell Biotechnologies Inc.: interest_expense
| Value | {"unit": "CNY", "value": 2155000, "concept": "us-gaap:InterestExpense"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | superseded |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/646889b2-99b0-485a-a4c6-20a5b250456c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-128979Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/interest-expense/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/646889b2-99b0-485a-a4c6-20a5b250456c
History
- no predecessors — first report